Webinar Date/Time: Wednesday, January 31st, 2024 at 9am EST | 6am PST | 2pm GMT | 3pm CET
Risk Based Quality Management has evolved significantly in last few years, with increasing adoption of centralization, remotization of activities, and AI driven analytics-based processes in clinical monitoring. In this session we aim to highlight the impact digital transformation is having on RBQM methodology utilizing novel clinical technologies like mobility platforms and AI enabled technologies, patient generated data, and the convergence with delivery models like decentralized clinical trials.
Register Free: https://www.appliedclinicaltrialsonline.com/act/rbqm
Event overview
Risk Based Quality Management has evolved significantly in last few years, with increasing adoption of centralization, remotization of activities, and AI driven analytics-based processes in clinical monitoring.
In this webinar, we aim to highlight the impact digital transformation has had on RBQM methodology, how we are utilizing patient generated data, and implementing novel clinical technologies like mobility platforms and AI enabled technologies.
In addition, we will discuss the convergence with delivery models like decentralized clinical trials. Join us for this webinar as we discuss this ever-evolving landscape.
Three key take-aways
Speakers:
Jon Hill
Associate Director, Centralized Monitoring
IQVIA
Jon has been with IQVIA for 12 years and is an experienced clinical operations leader focused on driving digital strategy, innovation, and analytics. In his current role at IQVIA, Jon is involved in rethinking the future of clinical operations through the implementation of digital transformation strategies. He has a breadth of industry experience, having built transformative strategic partnerships, led operations teams, and managed sales strategy and analytics to fuel organizational growth.
Debjit Chakrabarti
Senior Director, Head of Centralized Monitoring FSP Services
IQVIA
Serving the IQVIA Centralized Monitoring business as Senior Director, Debjit leads the Centralized Monitoring FSP service large-scale operations team across multiple sponsors. He has 17 years of experience that spans Clinical Data Management, RBM/RBQM implementation, operational excellence, customer relationships, account management, leadership, and management.
Debjit has completed his master’s degree in biotechnology and been certified on ‘Leading Strategic Growth’ by Columbia Business School.
Register Free: https://www.appliedclinicaltrialsonline.com/act/rbqm
What Can ClinOps Learn from Pre-Clinical?
August 10th 2021Dr. Hanne Bak, Senior Vice President of Preclinical Manufacturing and Process Development at Regeneron speaks about her role at the company as well as their work with monoclonal antibodies, the regulatory side of manufacturing, and more.